2772-3925

Addiction Neuroscience

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 246 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact246 DOIs
2

Attach ORCID iDs across 89 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact89 DOIs
3

Deposit reference lists for 49 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact49 DOIs

DOIs for this ISSN

Showing the top 5 of 246 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Adolescent alcohol exposure reduces dopamine 1 receptor modu… (10.1016/j.addicn.2022.100044)
Abstract ORCID
74.57 30
2 Gray matter volumes of the insula and anterior cingulate cor… (10.1016/j.addicn.2021.100003)
Abstract ORCID
67.12 21
3 Optogenetic stimulation of dynorphinergic neurons within the… (10.1016/j.addicn.2022.100005)
Abstract ORCID
65.05 19
4 Incubation of cocaine craving coincides with changes in dopa… (10.1016/j.addicn.2022.100029)
Abstract ORCID
65.05 19
5 Biomarkers of improved health outcomes after smoking cessati… (10.1016/j.addicn.2022.100054)
Abstract ORCID
65.05 19
6 Alcohol-drinking during later life by C57BL/6J mice induces… (10.1016/j.addicn.2023.100099)
Abstract ORCID
61.52 16
7 Contextual processing and its alterations in patients with a… (10.1016/j.addicn.2023.100100)
Abstract ORCID
53.96 11
8 Chronic oral methylphenidate plus fluoxetine treatment in ad… (10.1016/j.addicn.2023.100127)
Abstract ORCID
53.96 11
9 Problem drinking and the interaction of reward, negative emo… (10.1016/j.addicn.2021.100004)
Abstract ORCID
52.07 10
10 Fluoxetine potentiates methylphenidate-induced behavioral re… (10.1016/j.addicn.2023.100131)
Abstract ORCID
52.07 10
11 BDNF as a therapeutic candidate for cocaine use disorders (10.1016/j.addicn.2022.100006)
Abstract ORCID
50.00 9
12 Prelimbic cortex and nucleus accumbens core resting state si… (10.1016/j.addicn.2023.100097)
Abstract ORCID
50.00 9
13 Brain stimulation therapeutics (10.1016/j.addicn.2023.100080)
Abstract ORCID
47.71 8
14 Genomic medicine to reduce tobacco and related disorders: Tr… (10.1016/j.addicn.2023.100083)
Abstract ORCID
47.71 8
15 Recent advances in drug discovery efforts targeting the sigm… (10.1016/j.addicn.2023.100126)
Abstract ORCID
47.71 8
16 Medication adherence in tobacco cessation clinical trials (10.1016/j.addicn.2023.100069)
Abstract ORCID
45.15 7
17 Electronic Vaporization of Nicotine Salt or Freebase produce… (10.1016/j.addicn.2023.100082)
Abstract ORCID
45.15 7
18 Individual differences in late positive potential amplitude… (10.1016/j.addicn.2023.100106)
Abstract ORCID
45.15 7
19 Xylazine is an agonist at kappa opioid receptors and exhibit… (10.1016/j.addicn.2024.100155)
Abstract
43.70 55
20 Classic and non‐classic psychedelics for substance use disor… (10.1016/j.addicn.2022.100025)
Abstract
42.90 51
21 Kappa-opioid receptor activation reinstates nicotine self-ad… (10.1016/j.addicn.2022.100017)
Abstract ORCID
42.25 6
22 Using lickometry to infer differential contributions of sali… (10.1016/j.addicn.2023.100102)
Abstract ORCID
42.25 6
23 Recruitment of specific dopamine neuron sub-circuits by opio… (10.1016/j.addicn.2025.100233)
Abstract ORCID
42.25 6
24 Central amygdala neuroimmune signaling in alcohol use disord… (10.1016/j.addicn.2024.100194)
Abstract ORCID
38.91 5
25 Neural circuit mechanisms of the cholecystokinin (CCK) neuro… (10.1016/j.addicn.2022.100024)
Abstract
37.28 30
26 Challenges and new opportunities for detecting endogenous op… (10.1016/j.addicn.2022.100016)
Abstract
36.18 27
27 Epigenetic biomarkers for smoking cessation (10.1016/j.addicn.2023.100079)
Abstract
35.78 26
28 Actions of feeding-related peptides on the mesolimbic dopami… (10.1016/j.addicn.2022.100011)
Abstract
34.95 24
29 Unfolding the real-time neural mechanisms in addiction: Func… (10.1016/j.addicn.2022.100048)
Abstract
34.95 24
30 Sex differences in addiction-relevant behavioral outcomes in… (10.1016/j.addicn.2023.100067)
Abstract
34.95 24
31 The role of sex hormones in targeting stress-induced tobacco… (10.1016/j.addicn.2023.100084)
Abstract ORCID
34.95 4
32 The need to incorporate polysubstance use in neuropsychophar… (10.1016/j.addicn.2025.100246)
Abstract ORCID
34.95 4
33 Ventral pallidum GABA neurons bidirectionally control opioid… (10.1016/j.addicn.2022.100026)
Abstract
34.51 23
34 Biomarkers of Electronic Nicotine Delivery Systems (ENDS) us… (10.1016/j.addicn.2023.100077)
Abstract
34.51 23
35 Estradiol and Mu opioid-mediated reward: The role of estroge… (10.1016/j.addicn.2023.100139)
Abstract
34.51 23
36 The roles of rat medial prefrontal and orbitofrontal cortice… (10.1016/j.addicn.2022.100031)
Abstract
34.04 22
37 Prefrontal cortex glutamatergic adaptations in a mouse model… (10.1016/j.addicn.2023.100137)
Abstract
34.04 22
38 Extended access to fentanyl vapor self-administration leads… (10.1016/j.addicn.2022.100057)
Abstract
33.06 20
39 Corticotropin releasing factor and drug seeking in substance… (10.1016/j.addicn.2022.100038)
Abstract
32.53 19
40 The novel psychoactive substances epidemic: A scientometric… (10.1016/j.addicn.2022.100060)
Abstract
32.53 19
41 HPA axis function in alcohol use disorder: A systematic revi… (10.1016/j.addicn.2023.100114)
Abstract
31.97 18
42 Sex-related differences in endogenous pituitary adenylate cy… (10.1016/j.addicn.2022.100058)
Abstract
31.38 17
43 The Effects of the Inhalant Toluene on Cognitive Function an… (10.1016/j.addicn.2022.100059)
Abstract
31.38 17
44 Proportion and distribution of neurotransmitter-defined cell… (10.1016/j.addicn.2024.100183)
Abstract
31.38 17
45 Chst9 marks a spatially and transcriptionally unique populat… (10.1016/j.addicn.2024.100153)
Abstract
30.76 16
46 Cingulate circuits are associated with escalation of heroin… (10.1016/j.addicn.2021.100002)
Abstract ORCID
30.10 3
47 Effects of buprenorphine, methadone, and cariprazine on econ… (10.1016/j.addicn.2023.100065)
Abstract ORCID
30.10 3
48 Predictors of smoking cessation outcomes identified by machi… (10.1016/j.addicn.2023.100068)
Abstract
30.10 15
49 Genomic and behavioral signatures of selection for ethanol p… (10.1016/j.addicn.2025.100209)
Abstract ORCID
30.10 3
50 Estrous cycle and hormone regulation of stress-induced reins… (10.1016/j.addicn.2022.100035)
Abstract
29.40 14